Page 42 - Lipids News Today

Cardiovascular risk factors are "unacceptably" high and are increasing among US adults aged 20 to 44 years, prompting calls for aggressive preventive measures.

A daily 40-mg dose of atorvastatin for 12 months significantly cut incident cardiac dysfunction in patients with lymphoma receiving anthracycline treatment.

In stent placement for complex coronary lesions, intravascular imaging reduces events relative to angiography.

The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL-lowering therapies, experts say.

Mumbai (Maharashtra) [India], March 1 (ANI/NewsVoir): VAV Lipids has announced that it received a Certificate of Appreciation from United States Pharmacopeia (USP) for its contribution to the standards-setting activities in lipid manufacturing.

A simple skin management program can help kids keep using critical diabetes treatment devices, researchers reported.

Healthcare professionals should be asking all patients about their sleep — just as they would ask about diet and exercise — as a key aspect of maintaining heart health, says a sleep expert.

Textbooks will tell you that in dividing cells, the production of new DNA peaks during the S-phase, while production of other macromolecules, such as proteins, lipids, and polysaccharides, continues at more or less the same level.

Patients with multiple sclerosis who cut calories 2 days per week not only lost weight in a new study, they also showed better cognition and other positive outcomes.

A research team at the University of the Basque Country has spent 9 years monitoring gluten-free products to analyze whether they are nutritionally deficient.